Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
51,317,788
-
Share change
-
-2,935,220
-
Total reported value
-
$2,500,081,174
-
Put/Call ratio
-
61%
-
Price per share
-
$48.74
-
Number of holders
-
296
-
Value change
-
-$235,189,883
-
Number of buys
-
149
-
Number of sells
-
170
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2025
As of 30 Sep 2025,
HAEMONETICS CORP - Common Stock (HAE) was held by
296 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,317,788 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, River Road Asset Management, LLC, UBS Group AG, ROYAL BANK OF CANADA, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
296
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.